Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|January 18, 2018
Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World StudySara Charleer, Chantal Mathieu, Frank Nobels, et al.The Journal of Clinical Endocrinology and Metabolism|September 17, 2021
Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes MellitusAnass El Malahi, Michiel Van Elsen, Sara Charleer, et al.Heliyon|April 8, 2025
The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progressionJulie Vandewalle, Aster K Desouter, Bart J Van der Auwera, et al.Diabetes, Obesity & Metabolism|August 28, 2024
Health-related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT-ONENele Steenackers, Thomas Sparsø, Sara Charleer, et al.Diabetologia|January 18, 2024
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in BelgiumMargaretha M Visser, Astrid Van Muylder, Sara Charleer, et al.Diabetes Care|October 17, 2020
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE StudySara Charleer, Christophe De Block, Frank Nobels, et al.Lancet (London, England)|June 5, 2021
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trialMargaretha M Visser, Sara Charleer, Steffen Fieuws, et al.The Lancet. Diabetes & Endocrinology|January 26, 2023
Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trialMargaretha M Visser, Sara Charleer, Steffen Fieuws, et al.Journal of Diabetes Science and Technology|September 29, 2022
The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 TrialMargaretha Martha Visser, Sara Charleer, Steffen Fieuws, et al.Diabetologia|June 18, 2018
Decreasing rates of major lower-extremity amputation in people with diabetes but not in those without: a nationwide study in BelgiumHeiner Claessen, Herve Avalosse, Joeri Guillaume, et al.Pageof 7